Houston, TX -- (SBWIRE) -- 01/23/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) added 0.08% and is trading at $37.94. Teva Pharmaceutical Industries Ltd (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect.
Can TEVA Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Cyberonics, Inc. (NASDAQ:CYBX) is lower 7.28% and is trading at $44.60. Cyberonics, Inc. (Cyberonics) is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.
How Should Investors Trade CYBX After The Recent Volatile Moves? Find Out Here
Johnson & Johnson (NYSE:JNJ) is higher 0.03% and is trading at $72.71. Johnson & Johnson is a holding company. The Company, along with its subsidiaries, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.
Is JNJ Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
NuPathe Inc (NASDAQ:PATH) added 9.50% and is trading at $3.92. NuPathe, Inc. develops therapeutics for diseases of the central nervous system including neurological and psychiatric disorders. The Companys products are NP201 for the continuous symptomatic treatment of Parkinson's disease and NP202 for the long-term treatment of schizophrenia and bipolar disorder.
Can PATH Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Myrexis Inc (NASDAQ:MYRX) is higher 4.32% and is trading at $2.90. Myrexis Inc, is a biopharmaceutical company that has generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. The Company retains all rights to all of its drug candidates and programs across all geographic markets and therapeutic indications. In February 2012, the Company suspended development activities in oncology programs and are actively pursuing business development opportunities with respect to them.
Is MYRX Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)